CAS 120601-66-3: b-D-Glucopyranoside,(1S)-2-hydroxy-1-[[[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propenyl]oxy]methyl]ethyl(9CI)

Regaloside D is a natural product derived from plant sources, specifically isolated from certain species known for their bioactive properties. It functions as a glycoside, a compound in which a sugar is bound to a non-carbohydrate moiety, potentially influencing a variety of cellular processes through its interaction with specific molecular targets. The mode of action of Regaloside D involves modulation of protein activity and signaling pathways. By binding to particular enzyme sites or receptors, it can incite changes in cellular pathways that are crucial for both normal physiology and disease processes. This ability to interact at a molecular level makes it a compound of significant interest for understanding pathophysiological mechanisms and developing therapeutic interventions. Regaloside D's applications pertain largely to the fields of pharmacology and biochemistry, where it is explored for its potential roles in therapeutic strategy development, particularly within oncology and inflammation research. Investigators aim to elucidate its effects within complex biological systems, potentially leading to advances in drug discovery and development. Its multifaceted interactions highlight the importance of this compound in advancing our understanding of cellular dynamics and disease treatment.

Regaloside D is a natural product isolated from Lilium Longiflorum.